Aspergillosis (Brooder Pneumonia)

Aspergillosis, commonly known as brooder pneumonia when it affects young poultry, is a serious fungal infection caused by Aspergillus species, primarily Aspergillus fumigatus. This opportunistic fungal disease affects the respiratory system of chickens, ducks, geese, and other poultry species, causing significant morbidity and mortality particularly in young birds and those with compromised immune systems. The condition is one of the most common fungal diseases encountered in commercial and backyard poultry operations worldwide, representing a significant economic and welfare concern for poultry keepers.

The disease develops when birds inhale fungal spores that are ubiquitous in the environment, particularly in moldy feed, contaminated bedding material, and poorly ventilated housing. Unlike many poultry diseases, aspergillosis is not directly contagious from bird to bird but rather results from environmental contamination. The fungal spores germinate in the warm, moist environment of the avian respiratory tract, establishing infection in the lungs, air sacs, and sometimes spreading to other organs. Young chicks and ducklings are particularly vulnerable during the brooding period when they may be exposed to contaminated incubators, hatchers, or brooder environments.

The impact of aspergillosis on affected poultry can be devastating, ranging from acute, rapidly fatal disease in young birds to chronic, debilitating illness in older poultry. Affected birds experience progressive respiratory compromise that significantly impacts their quality of life, growth rate, and productivity. The disease can cause substantial economic losses in commercial operations through mortality, reduced growth performance, increased medication costs, and condemnation of affected carcasses at processing. For backyard poultry keepers, the emotional toll of losing birds to this preventable disease can be significant.

Treatment of aspergillosis in poultry presents considerable challenges, as fungal infections are inherently more difficult to treat than bacterial diseases. While antifungal medications can be effective when administered early in the disease course, advanced cases often carry a poor prognosis. Prevention through proper environmental management, including maintaining clean, dry bedding, ensuring adequate ventilation, and avoiding moldy feed, remains the cornerstone of controlling this disease. Early recognition of clinical signs and prompt veterinary intervention are essential for the best possible outcomes in affected birds.

The primary cause of aspergillosis in poultry is infection with fungi belonging to the Aspergillus genus, with Aspergillus fumigatus being the most common pathogenic species. This ubiquitous mold produces millions of microscopic spores called conidia that become airborne and can be inhaled by birds during normal respiration. Other Aspergillus species, including A. flavus, A. niger, and A. terreus, can also cause disease, though less frequently. The fungus thrives in warm, humid environments and is commonly found in decomposing organic matter, making poultry housing environments particularly conducive to fungal growth when proper management practices are not followed.

Genetic and species-related factors play a significant role in susceptibility to aspergillosis. While all poultry species can develop the disease, certain species demonstrate increased vulnerability. Waterfowl, including ducks and geese, appear particularly susceptible to aspergillosis, possibly due to differences in their respiratory anatomy and natural behaviors. Turkey poults and young chickens are also highly susceptible, especially during the first few weeks of life when their immune systems are still developing. Individual genetic variation in immune function may also influence susceptibility, though specific genetic markers for resistance have not been well characterized in poultry.

Environmental and husbandry factors are the most critical determinants of aspergillosis risk in poultry operations. Contaminated bedding material, particularly wood shavings, straw, or hay that has become damp or moldy, serves as a major source of fungal spores. Improper storage of feed and bedding materials in humid conditions promotes fungal growth. Inadequate ventilation in poultry houses allows moisture and spore concentrations to build up to dangerous levels. Poor sanitation in incubators and hatchers can expose embryos and newly hatched chicks to high spore loads during their most vulnerable period. Overcrowding and stressful conditions that compromise immune function also increase disease risk.

Several risk factors predispose individual birds or flocks to developing aspergillosis. Age is a primary risk factor, with very young birds and aged poultry being most susceptible. Immunosuppression from any cause, including concurrent infections, nutritional deficiencies, mycotoxin exposure, or stress, dramatically increases susceptibility. Birds recovering from other respiratory infections or those receiving prolonged antibiotic therapy may have altered respiratory defenses that favor fungal colonization. Poor nutrition, particularly deficiencies in vitamin A and other nutrients essential for maintaining respiratory epithelium integrity, can predispose birds to infection.

The mechanism of disease development begins when inhaled spores reach the lower respiratory tract and air sacs, where they encounter conditions favorable for germination. The warm body temperature of birds (approximately 40-42°C) is optimal for Aspergillus growth. Once spores germinate, fungal hyphae begin to invade respiratory tissues, causing inflammation and tissue destruction. The fungus produces various enzymes and toxins that damage host tissues and evade immune responses. In birds with adequate immune function, the infection may be contained as localized granulomas, but in immunocompromised individuals, the fungus can spread throughout the respiratory system and disseminate to other organs including the brain, kidneys, and eyes.

Early warning signs of aspergillosis in poultry are often subtle and can be easily overlooked, particularly in large flocks. Affected birds may initially show only mild lethargy and a slight decrease in activity levels compared to flockmates. A subtle change in breathing pattern, including slightly increased respiratory rate or mild open-mouth breathing during rest, may be the first indication of respiratory involvement. Feed consumption may decrease marginally before other signs become apparent. In young chicks, failure to thrive or grow at the expected rate compared to siblings can be an early indicator of developing infection. These early signs are frequently missed because poultry naturally hide signs of illness as a survival mechanism.

The most common symptoms of aspergillosis involve progressive respiratory compromise. Affected birds develop labored breathing characterized by tail bobbing, neck extension, and exaggerated abdominal movements with each breath. Gasping and open-mouth breathing become increasingly evident as the disease progresses. A characteristic rattling or gurgling sound may be heard when handling affected birds or when they breathe. Nasal discharge may be present in some cases, though this is not always a prominent feature. Decreased feed and water consumption accompany respiratory distress, leading to weight loss and dehydration. Cyanosis, or bluish discoloration of the comb and wattles, may develop in advanced cases due to inadequate oxygenation.

Behavioral changes in birds with aspergillosis reflect their declining health status and respiratory distress. Affected birds become increasingly inactive and may separate themselves from the flock, often sitting hunched with ruffled feathers. They show reduced interest in their surroundings and decreased responsiveness to stimuli that would normally provoke a reaction. Feed and water consumption drops significantly as birds feel too unwell to eat. Vocalizations may change, with birds becoming quieter or producing abnormal sounds due to respiratory involvement. In laying hens, egg production typically ceases as the bird's energy is redirected toward fighting infection.

Physical signs observable by poultry keepers include poor body condition with prominent keel bone due to weight loss. Feathers often appear dull, ruffled, and unkempt as birds cease normal preening behaviors. The comb and wattles may appear pale or cyanotic depending on the degree of respiratory compromise. In some cases, swelling around the eyes or face may be noted if infection involves the sinuses. Droppings may become abnormal, often appearing green due to bile pigment when birds stop eating. Neurological signs including incoordination, head tilt, or seizures may develop if the fungus spreads to the central nervous system.

Symptom progression in aspergillosis typically follows a predictable pattern if left untreated. The acute form, most commonly seen in young poultry exposed to heavy spore loads, progresses rapidly over several days with severe respiratory distress leading to death. The chronic form develops more gradually over weeks to months, with birds showing slowly worsening respiratory signs and progressive weight loss. Periods of apparent improvement may alternate with episodes of clinical deterioration. Without treatment, chronic cases eventually develop severe respiratory compromise or systemic spread that proves fatal. The rate of progression depends on the immune status of the bird, the fungal burden, and environmental conditions.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with constant gasping and inability to rest, complete refusal to eat or drink for more than 24 hours, profound weakness or collapse, cyanosis of the comb and wattles indicating oxygen deprivation, and neurological signs such as seizures, head pressing, or inability to stand. Any bird showing rapid deterioration over hours rather than days should be considered an emergency case. Multiple birds in a flock developing severe respiratory signs simultaneously suggests a significant environmental contamination event requiring urgent investigation and intervention.

Initial examination of poultry suspected of having aspergillosis involves a thorough clinical assessment by a veterinarian experienced in avian medicine. The physical examination includes careful evaluation of respiratory function, noting breathing rate and effort, presence of abnormal respiratory sounds, and any evidence of nasal discharge or ocular involvement. Body condition is assessed to determine the degree of weight loss and overall health status. The veterinarian will gather a detailed history including the age of affected birds, duration of illness, environmental conditions, bedding and feed sources, and any recent changes in management. Information about mortality patterns and the number of birds affected helps determine whether the outbreak represents acute exposure to high spore levels or chronic environmental contamination.

Diagnostic testing for aspergillosis utilizes several approaches to confirm fungal infection. Blood work, including complete blood count and biochemistry panel, may reveal changes consistent with chronic infection and inflammation, though findings are often nonspecific. Radiography (X-rays) can reveal characteristic changes in the lungs and air sacs, including increased density, nodular lesions, or thickened air sac membranes. Endoscopy allows direct visualization of the air sacs and respiratory tract, enabling the veterinarian to observe fungal plaques and collect samples for laboratory analysis. Culture of respiratory samples or lesion material on fungal growth media allows identification of Aspergillus species, though growth may take several days. PCR testing can provide rapid detection and identification of Aspergillus DNA in clinical samples.

Differential diagnosis is essential because several conditions can produce respiratory signs similar to aspergillosis. Bacterial respiratory infections, including those caused by Mycoplasma, E. coli, and Pasteurella, must be distinguished from fungal disease through appropriate testing. Viral respiratory diseases such as infectious bronchitis and Newcastle disease can cause similar clinical presentations. Other fungal conditions and air sac mites may also produce respiratory signs. Internal parasites affecting the respiratory tract should be considered. The presence of concurrent infections is common, as immunosuppression from one disease often predisposes to secondary infections. Accurate differentiation is crucial because treatment approaches differ significantly between bacterial, viral, and fungal diseases.

Definitive diagnosis of aspergillosis is confirmed through a combination of clinical findings, diagnostic imaging, and laboratory identification of the causative organism. Demonstration of characteristic fungal hyphae on cytology of respiratory samples or tissue impressions provides strong evidence of infection. Culture and identification of Aspergillus species from affected tissues confirms the diagnosis. Histopathology of lesions obtained at necropsy or biopsy shows characteristic granulomatous inflammation with fungal elements visible on special staining. Severity assessment helps guide treatment decisions and prognosis, with factors including the extent of respiratory involvement, presence of systemic spread, and overall health status of the bird influencing the expected outcome.

Emergency and immediate treatment of severely affected poultry focuses on supportive care to stabilize the bird while antifungal therapy takes effect. Affected birds should be isolated in a warm, clean, well-ventilated environment away from other poultry to reduce stress and prevent potential disease spread. Providing supplemental heat, particularly for young birds, helps reduce metabolic demands on compromised respiratory systems. Oxygen supplementation may benefit birds in severe respiratory distress when available. Fluid therapy, administered orally or subcutaneously depending on the bird's condition, addresses dehydration that commonly accompanies decreased drinking. Nutritional support through easily digestible foods and vitamin supplementation supports the immune response. Removing birds from contaminated environments is essential to prevent continued spore exposure.

Medical management of aspergillosis centers on antifungal medication therapy. Itraconazole is considered the treatment of choice for aspergillosis in poultry, administered orally at species-appropriate doses for extended periods typically ranging from several weeks to months. Amphotericin B may be used in severe cases, though administration routes are limited and nephrotoxicity is a concern. Voriconazole represents another treatment option with good tissue penetration. Antifungal medications for poultry are often prescribed extra-label, requiring veterinary prescription and guidance for proper dosing and administration. Treatment duration is prolonged compared to bacterial infections because fungal organisms are more difficult to eliminate and premature discontinuation frequently results in relapse. Concurrent treatment of any secondary bacterial infections may be necessary.

Surgical intervention has limited application in poultry aspergillosis but may be considered in valuable individual birds with localized disease. Surgical removal of accessible fungal granulomas through air sac endoscopy has been described in pet and valuable breeding birds. Debridement of localized lesions can reduce fungal burden and improve response to medical therapy. However, surgery carries significant risks in birds with compromised respiratory function, and general anesthesia poses additional challenges in patients with respiratory disease. For most commercial and backyard poultry, surgical treatment is not practical or economically justified, and medical management remains the primary approach.

Supportive care plays a crucial role in treatment success and should continue throughout the treatment period. Maintaining optimal environmental temperature reduces energy expenditure on thermoregulation. Nebulization therapy with antifungal agents, saline, or mucolytics can help deliver medication directly to the respiratory tract and loosen accumulated debris. Providing high-quality, easily digestible nutrition supports immune function and maintains body condition during recovery. Vitamin A supplementation is particularly important as this vitamin supports respiratory epithelium health. Probiotics may help maintain gastrointestinal health during prolonged antifungal therapy. Stress reduction through appropriate housing, handling, and management practices supports healing.

Alternative and complementary treatments may be considered as adjuncts to conventional antifungal therapy. Nebulization with antifungal solutions provides direct delivery of medication to affected airways and has shown benefit in avian aspergillosis cases. Some practitioners incorporate immune-supporting supplements including vitamin C, E, and selenium into treatment protocols. Herbal remedies with antifungal properties have been explored in poultry, though scientific evidence for efficacy is limited. Environmental management, including improving ventilation and removing contamination sources, is essential regardless of medical treatment employed. These approaches should complement rather than replace proven antifungal medications.

Treatment decisions for aspergillosis must consider multiple factors beyond medical efficacy. Cost of prolonged antifungal therapy can be substantial, particularly for treatment of individual birds in backyard settings where medication must be purchased in quantities designed for larger animals. For commercial operations, treatment of individual birds is rarely economically viable, and management focuses on environmental correction and culling of affected birds. Owner commitment to prolonged treatment and medication administration schedules must be realistic. Prognosis varies considerably based on disease severity at diagnosis, with early intervention providing much better outcomes than treatment of advanced cases.

Recovery timeline for poultry with aspergillosis varies considerably based on disease severity, duration of illness before treatment, and individual bird factors. Birds with early-stage disease detected promptly may show improvement within one to two weeks of initiating appropriate antifungal therapy, though complete resolution requires continued treatment for four to eight weeks or longer. Birds with established chronic aspergillosis face a more prolonged recovery period, often requiring three to six months of treatment to achieve remission. Some birds may never fully recover normal respiratory function despite successful elimination of active infection due to permanent scarring and damage to the respiratory tract.

Post-treatment care requirements are extensive and demand significant owner commitment. Antifungal medications must be administered consistently as prescribed, with accurate dosing critical for treatment success. Birds should be maintained in clean, well-ventilated housing separate from the general flock until recovery is confirmed. Regular monitoring of weight, appetite, respiratory effort, and overall demeanor helps track recovery progress. Activity should be limited during the acute treatment phase to reduce respiratory demands, with gradual return to normal activity as improvement occurs. Follow-up veterinary examinations allow assessment of treatment response and adjustment of therapy if needed.

Prognosis for aspergillosis depends heavily on several factors that should be considered when setting expectations. Early detection and treatment initiation significantly improve outcomes, with birds diagnosed and treated in the early stages having reasonable prospects for recovery. Immune status plays a crucial role, as immunocompromised birds face greater challenges in clearing infection even with appropriate antifungal therapy. The extent and location of fungal lesions affect prognosis, with localized disease carrying better outlook than disseminated infection involving multiple organs. Age and overall health status influence the bird's ability to mount an effective immune response and tolerate prolonged treatment. Species differences in drug metabolism and disease susceptibility also affect outcomes.

Long-term outlook for recovered birds requires ongoing attention and realistic expectations. Birds that survive aspergillosis may have persistent respiratory compromise from scarring, making them more susceptible to respiratory stress and secondary infections throughout life. Recurrence is possible if birds are re-exposed to contaminated environments, making ongoing environmental management essential. Recovered birds may have reduced performance in terms of growth rate or egg production compared to unaffected flock mates. Regular monitoring for signs of relapse should continue for several months after treatment completion. With appropriate ongoing management, many recovered birds can enjoy a reasonable quality of life, though they may never return to full pre-disease condition.

Environmental prevention forms the cornerstone of aspergillosis control in poultry operations. Housing should be designed and maintained to provide adequate ventilation while preventing moisture accumulation that promotes fungal growth. Bedding materials should be stored in dry conditions and inspected for mold before use, with any moldy material rejected. Wet or soiled bedding should be removed promptly and replaced with fresh, dry material. Regular cleaning and disinfection of housing facilities, with particular attention to corners and areas where moisture accumulates, reduces fungal spore levels. Incubators and hatchers require meticulous cleaning and disinfection between batches to prevent contamination of eggs and newly hatched chicks. Maintaining appropriate stocking densities prevents moisture buildup from respiration and droppings.

Quarantine protocols help prevent introduction of aspergillosis into poultry flocks. While aspergillosis itself is not contagious between birds, new arrivals may introduce other diseases that immunosuppress resident birds, increasing their susceptibility to environmental fungi. All new poultry should be quarantined for a minimum of 30 days before introduction to established flocks. During quarantine, observe new birds for any signs of respiratory disease or other health problems. Testing for common poultry diseases during the quarantine period helps identify potential health issues. Quarantine housing should maintain the same high standards of ventilation and bedding management as production facilities.

Dietary prevention supports immune function and respiratory health in poultry. Providing balanced, species-appropriate nutrition ensures birds have the nutritional resources to maintain effective immune defenses. Feed should be stored properly in cool, dry conditions to prevent mold growth and mycotoxin contamination. Vitamin A supplementation is particularly important as deficiency predisposes birds to respiratory infections. Adequate protein intake supports immune function and tissue repair. Clean, fresh water should be available at all times, with water systems cleaned regularly to prevent biofilm accumulation. Avoid feeding moldy or spoiled feed, as mycotoxins produced by feed molds can suppress immune function.

Health maintenance practices reduce overall disease risk and support respiratory health. Regular veterinary consultation helps identify and address health issues before they become serious problems. While no vaccine exists for aspergillosis, maintaining vaccination schedules for other poultry diseases reduces immunosuppression from concurrent infections. Parasite control programs prevent parasitic infections that could compromise immune function. Monitoring flock health through regular observation and record keeping enables early detection of problems. Minimizing stress through appropriate handling, stable social groups, and consistent management routines supports overall health.

Early intervention at the first sign of respiratory problems greatly improves outcomes. Learn to recognize early signs of respiratory disease in poultry, including subtle changes in breathing, activity level, and appetite. Investigate any unexplained mortality promptly, including submission of fresh carcasses for necropsy when possible. Address environmental risk factors immediately when respiratory disease is suspected, including evaluation of bedding quality, ventilation, and potential contamination sources. Prompt veterinary consultation when respiratory signs appear allows early diagnosis and treatment before disease becomes advanced. Working proactively with an avian veterinarian to develop a flock health program helps prevent problems before they occur.

Daily management of poultry recovering from or living with chronic aspergillosis requires consistent attention to both medical treatment and environmental factors. Medications must be administered accurately and on schedule, with careful attention to proper dosing for the individual bird's weight. Monitoring daily food and water intake provides important information about the bird's overall condition and appetite. Observing respiratory effort during routine activities helps track disease status and identify any deterioration that might indicate treatment failure or relapse. Weighing birds regularly, ideally weekly during active treatment, allows objective tracking of recovery progress. Maintaining written records of medications given, clinical observations, and weights helps track trends over time.

Home environment modifications are essential for birds recovering from aspergillosis. Housing should provide excellent ventilation while avoiding direct drafts on recovering birds, as respiratory-compromised birds are more sensitive to temperature extremes. Bedding must be kept scrupulously clean and dry, with more frequent changes than would typically be required for healthy birds. Dust should be minimized through appropriate bedding choices and regular cleaning without creating dusty conditions during cleaning activities. Separating recovering birds from the general flock reduces competition for food and water and allows closer monitoring. Temperature control is important as birds with respiratory compromise have difficulty maintaining body temperature, particularly in cold conditions.

Maintaining quality of life for affected birds requires balancing treatment needs with the bird's behavioral and social needs. While isolation may be necessary during acute treatment, recovered birds benefit from visual contact with other poultry to reduce stress from social isolation. Providing appropriate enrichment such as perches at comfortable heights, foraging opportunities, and space for normal behaviors supports mental well-being. Birds with chronic respiratory compromise may have reduced exercise tolerance and should not be forced to compete with healthier flock mates for resources. Ensuring easy access to food and water without physical exertion helps maintain nutrition in birds with limited energy reserves.

Monitoring and ongoing veterinary care remain important throughout recovery and beyond. Regular follow-up examinations allow assessment of treatment response and adjustment of therapy as needed. Owners should maintain communication with their veterinarian about any changes in the bird's condition between scheduled appointments. Learn to recognize signs that might indicate relapse or treatment failure, including any return of respiratory signs, decreased appetite, or weight loss. Long-term monitoring for recurrence is advisable for several months after treatment completion. Birds with permanent respiratory damage may require periodic veterinary assessment to monitor for secondary complications.

Caregiver support is an important consideration when managing chronic disease in poultry. Treatment of aspergillosis requires significant time commitment for medication administration, environmental management, and monitoring. Financial costs of prolonged treatment and veterinary care can be substantial and should be realistically assessed when making treatment decisions. Connecting with online poultry keeping communities can provide emotional support and practical advice from others who have managed similar conditions. Setting realistic expectations about outcomes helps prevent disappointment and supports decision-making about treatment intensity and duration. Recognizing when palliative care rather than aggressive treatment best serves the bird's welfare is an important consideration in advanced cases.

High-risk species for aspergillosis include waterfowl, which demonstrate particular susceptibility to this fungal infection. Ducks and geese develop aspergillosis more frequently than chickens under similar environmental conditions, possibly due to their natural behaviors and respiratory anatomy. Waterfowl housed in conditions that do not accommodate their need for water and proper humidity management face elevated risk. Young waterfowl, particularly ducklings and goslings in the first few weeks of life, are extremely vulnerable to acute brooder pneumonia from environmental spore exposure. Turkey poults also demonstrate high susceptibility to aspergillosis, with outbreaks in commercial turkey operations causing significant economic losses. Among chicken breeds, no clear breed predilection has been established, though young chicks of any breed are highly susceptible during the brooding period.

Moderate-risk species and categories include adult poultry of all species, particularly when exposed to predisposing factors. Older birds past their productive prime may have declining immune function that increases susceptibility. Birds of any age with concurrent health problems, including parasitic infections, nutritional deficiencies, or other immunosuppressive conditions, face elevated risk. Poultry maintained in intensive production systems may experience stress-related immunosuppression that predisposes to infection. Show birds and exhibition poultry subjected to transport stress and exposure at shows may have temporarily reduced resistance. Rare or heritage breeds are not inherently more susceptible but may receive different management that affects exposure and risk.

Screening and health testing recommendations for aspergillosis focus on environmental monitoring and health surveillance rather than routine testing of individual birds. Regular inspection of feed and bedding for mold contamination helps identify risk before disease occurs. Necropsy examination of any birds dying with respiratory signs allows early detection of aspergillosis in a flock. When aspergillosis is diagnosed, environmental sampling for fungal spore levels can help identify contamination sources. Breeding stock for valuable genetics should be maintained in environments with excellent air quality and minimal fungal spore exposure. Working with veterinarians experienced in poultry health helps establish appropriate monitoring protocols based on specific operation characteristics and risk factors.

Commonly co-occurring conditions with aspergillosis reflect the immunosuppressive nature of predisposing factors. Bacterial respiratory infections frequently develop as secondary complications when fungal disease compromises the respiratory tract's normal defenses. Mycoplasma infections, which are endemic in many poultry populations, may be present concurrently and contribute to respiratory compromise. Nutritional deficiencies, particularly vitamin A deficiency, both predispose to aspergillosis and may be identified during diagnostic workup. Mycotoxicosis from contaminated feed often accompanies aspergillosis since both conditions result from fungal contamination of the bird's environment. Concurrent parasitic infections that cause immunosuppression may need to be addressed alongside aspergillosis treatment for optimal outcomes.

Conditions with similar symptoms to aspergillosis include various respiratory diseases that require differentiation for appropriate treatment. Infectious bronchitis, a viral disease, causes similar respiratory signs but follows different epidemiological patterns and does not respond to antifungal treatment. Chronic respiratory disease caused by Mycoplasma produces persistent respiratory signs that may be confused with chronic aspergillosis. Air sac mites cause respiratory distress in heavily infected birds and should be considered in the differential diagnosis. Newcastle disease produces severe respiratory signs along with neurological symptoms in some forms. Bacterial pneumonia from various pathogens may appear clinically similar to aspergillosis. Accurate diagnosis through appropriate testing is essential as treatment approaches differ substantially between these conditions.

Potential complications of aspergillosis can develop during the disease course or as sequelae in recovered birds. Systemic dissemination occurs when the fungus spreads from the respiratory tract to other organs, including the brain, kidneys, and eyes, dramatically worsening prognosis. Secondary bacterial infections are common complications as damaged respiratory tissues become colonized by opportunistic bacteria. Permanent respiratory damage including fibrosis and scarring may persist after successful treatment, leaving birds with chronic respiratory compromise. Malnutrition and muscle wasting develop from prolonged illness and decreased food intake. Recognizing these complications early allows adjustment of treatment protocols and helps set realistic expectations for long-term outcomes.